Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04675476 · ClinicalTrials.gov registry record · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
A NA study of Lung Cancer, sponsored by Georgetown University.
- Recruiting
- Registry status
- NA
- Development phase
- 368
- Enrollment target
- 1
- Study location
NCT04675476: Recruiting NA study of Lung Cancer, sponsored by Georgetown University.
NCT04675476 is a NA study of Lung Cancer that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 368 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04675476, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Georgetown University.
- RECRUITING
- Registry status
- NA
- Development phase
- 368 participants
- Enrollment target
- 1
- Study location
Study Summary
To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.
Primary Outcome
Discussion about lung screening with the provider ('did you have a discussion with your doctor about lung screening?')
Conditions Studied
Interventions
- BEHAVIORAL Provider Prompt & Patient Outreach and Education
Study Locations (1)
District of Columbia
- MedStar Health - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2024-03-11 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What NCT04675476 shows while recruiting
NCT04675476 is an interventional study that assigns participants to a tested intervention. The registered 368 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Provider Prompt & Patient Outreach and Education is the first listed.
NCT04675476 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04675476 about?
NCT04675476 is a clinical study titled "A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening". To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.
What is the current status of trial NCT04675476?
This trial is currently recruiting. It is a NA study. The enrollment target is 368 participants. The study started on 2024-03-11. Estimated completion is 2026-02-28.
What conditions does trial NCT04675476 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT04675476?
The interventions under investigation include: Provider Prompt & Patient Outreach and Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT04675476?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04675476 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04675476's enrollment target sits among peer trials
368 84th of 409 higher than 326 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Virtual Agent Feasibility in Oncology Patients (NTT Data)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
- NCT06114836 · 369 participants · NA
GERD Infant Feeding Therapeutics Trial (GIFT Trial)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI